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The association between ruptured abdominal
aortic aneurysm (AAA) and hyperamylasemia has
been described frequently in standard surgical text-
books.1,2 Furthermore, in a study of 25 patients
who underwent attempted repair of ruptured AAA,
Bagley et al3 reported that elevated serum total amy-
lase levels were associated with increased morbidity
and mortality and prolonged stay in the intensive
therapy unit. They further suggested that the hyper-
amylasemia observed in their patients was of pancre-
atic origin and was, therefore, a marker of ischemic
injury. However, the serum total amylase level is
determined by the level of the pancreatic isoenzyme,
which is specific to pancreas, and the salivary isoen-
zyme, which has been found in salivary glands, small
intestine, kidney, and lung.
The aims of this study were to define the source
of serum amylase in patients who undergo operation
for ruptured and non-ruptured AAA and to deter-
mine the prognostic significance of serum amylase
isoenzyme levels in patients who undergo operation
for ruptured AAA.
MATERIALS AND METHODS
The study period was from January 1, 1996, to
December 31, 1997. Forty consecutive patients (32
men and 8 women; median age, 74 years; range, 56
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Methods: This study was designed as a prospective clinical and laboratory study. The
study consisted of 40 patients who underwent operation for ruptured AAA and 10
patients who underwent operation for non-ruptured AAA. The main outcome measures
were serum total and pancreatic and salivary amylase activities determined with enzy-
matic colorimetric assay before operation and 6 hours after aortic clamp release.
Results: Five of 40 patients (12.5%) with rupture and one of 10 patients (10%) with non-
rupture had elevated total amylase levels before operation, and seven of 31 patients
(23%) with rupture and five of 10 patients (50%) with non-rupture had elevated total
amylase levels after operation. The preoperative salivary amylase (P = .05) and postop-
erative pancreatic amylase (P < .02) levels were significantly lower in ruptured AAA as
compared with non-ruptured AAA. The preoperative salivary amylase level was signifi-
cantly lower in non-survivors of rupture, such that a level equal to or less than 45 U/L
was associated with death in 11 of 13 patients (85%).
Conclusion: These data do not support previous works that suggest that hyperamy-
lasemia is associated with poor outcome in ruptured AAA. By contrast, a low preopera-
tive salivary amylase level was associated with increased mortality in ruptured AAA and
may be a marker of the severity of shock. (J Vasc Surg 1999;30:229-35.)
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to 86 years) who underwent emergent operation for
ruptured AAA and 10 consecutive patients (8 men
and 2 women; median age, 69 years; range, 58 to 80
years) who underwent elective operation for asymp-
tomatic non-ruptured AAA were prospectively stud-
ied. Ruptured AAA was confirmed at operation and
was defined as the presence of retroperitoneal blood
in the absence of any other identifiable cause for
hematoma other than an aneurysm. Thirty-four
patients (85%) with ruptured AAA had at least one
documented episode of hypotension (systolic blood
pressure, <100 mm Hg) before operation. In the
patients who underwent operation for asymptomatic
non-ruptured AAA, the median anteroposterior
diameter of the aneurysm measured by means of
abdominal ultrasound scanning was 6.5 cm (range,
5.5 to 8.0 cm). Of the 50 patients studied, 48 had
infrarenal AAAs that necessitated infrarenal aortic
clamping. Two patients with rupture had juxtarenal
aneurysms that necessitated suprarenal (but not
supracoeliac) aortic clamping. No patients in either
group had a history of pancreatic, biliary, or salivary
gland disease.
In all the patients, a 15-mL sample of blood was
obtained from an indwelling arterial line immediately
before anesthetic induction. In those patients who sur-
vived the surgery, a further 15-mL sample of blood
was obtained 6 hours after aortic clamp release.
Preoperative serum creatinine and hematocrit levels
were measured in the routine laboratory examinations.
For amylase isoenzyme estimation, the serum samples
were separated by means of centrifugation within 30
minutes of sampling and were stored at –70°C for later
batch analysis. Total and pancreatic amylase (1,4-a -D-
glucan 4-glucanohydrolase; EC 3.2.1.1) activities were
measured by enzymatic colorimetric assay with the
Hitachi 717 analyser and ethylidene-protected assay
kits (Boehringer Mannheim, Lewes, Sussex, United
Kingdom), according to the manufacturer’s protocols.
For the measurement of pancreatic amylase activity,
salivary amylase activity was inhibited by pre-incuba-
tion with two different anti-salivary amylase mono-
clonal antibodies, which have no effect on pancreatic
amylase activity but are associated with a residual sali-
vary amylase activity of less than 5%. Salivary amylase
activity was determined by subtracting the value for
pancreatic amylase from the corresponding value for
total amylase. The normal laboratory range for total
amylase is less than 220 U/L and for pancreatic amy-
lase is 17 to 115 U/L. The Mann-Whitney test was
used for all statistical analysis. A P value equal to or less
than .05 was regarded as statistically significant.
RESULTS
There were no deaths among the patients who
underwent repair of non-ruptured AAA: nine patients
had uncomplicated postoperative recoveries, and one
patient developed acute renal failure and congestive
cardiac failure. Twenty patients (50%) who underwent
operation for ruptured AAA died: eight during
attempted repair; one from coagulopathy and cardio-
genic shock in the anesthetic room after operation and
before transfer to the intensive therapy unit; and 11 in
the postoperative period from acute renal failure (n =
8), respiratory failure (n = 5), coagulopathy (n = 4),
critical lower extremity ischemia (n = 4), cardiac failure
(n = 3), and sepsis syndrome (n = 2). Of the 20
patients with ruptured AAA who survived, six had an
uncomplicated postoperative recovery. Major compli-
cations that occurred in the remaining 14 survivors
included cardiac failure (n = 8), coagulopathy (n = 5),
acute renal failure (n = 4), respiratory failure (n = 2),
cerebrovascular accident (n = 2), and sepsis syndrome
(n = 1). No patients with non-ruptured or ruptured
AAA had clinical evidence of postoperative pancreatitis.
There was no significant difference in operation
time for non-ruptured AAA (median time, 160 min-
utes; range, 85 to 285 minutes) as compared with rup-
tured AAA (median time, 135 minutes; range, 60 to
300 minutes; P = .4); in aortic clamp time for non-
ruptured AAA (median time, 75 minutes; range, 40 to
120 minutes) as compared with ruptured AAA (medi-
an time, 75 minutes; range, 30 to 210 minutes; P =
.6); or in operative blood loss for non-ruptured AAA
(median loss, 2400 mL; range, 400 to 6000 mL) as
compared with ruptured AAA (median loss, 2300 mL;
range, 550 to 11,200 mL; P = .5). The serum creati-
nine level before operation was significantly elevated in
patients with ruptured AAA (median level, 127
m mol/L; range, 77 to 234 m mol/L) as compared with
non-ruptured AAA (median level, 93 m mol/L; range,
63 to 128 m mol/L; P < .01), but there was no signif-
icant difference in the preoperative creatinine level
between survivors and non-survivors of rupture. The
hematocrit level before operation was significantly
lower in ruptured AAA (median level, 0.31; range,
0.12 to 0.45) as compared with non-ruptured AAA
(median level, 0.42; range, 0.33 to 0.47; P < .001) and
was lowest in non-survivors of rupture (median level,
0.26; range, 0.12 to 0.4) versus survivors (median
level, 0.33; range, 0.13 to 0.45; P < .02).
There was no significant relationship between
preoperative or postoperative total, pancreatic, or
salivary amylase and operation time, aortic clamp
time, or operative blood loss in either group. Before
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operation, one of two patients with rupture who
required suprarenal aortic clamping had elevated
total amylase (229 U/L), but neither patient had an
elevated pancreatic amylase isoenzyme level and the
proportion of amylase that was pancreatic in origin
was 33% and 46%. Six hours after operation, neither
patient had elevated total amylase or pancreatic amy-
lase isoenzyme levels and the proportion of amylase
that was pancreatic in origin was 50% and 54%.
Total amylase level was elevated before operation
in one of 10 patients (10%) with non-ruptured AAA
who had a pancreatic amylase isoenzyme level with-
in the normal range (108 U/L), and the proportion
of amylase that was pancreatic in origin was 48%.
Total amylase level was elevated before operation in
five of 40 patients (12.5%) with ruptured AAA. Only
one patient had an elevated pancreatic amylase
isoenzyme level (174 U/L), and the proportion of
amylase activity that was pancreatic in origin was
20%, 31%, 42%, 46%, and 56%.
Six hours after operation, five of 10 patients
(50%) with non-ruptured AAAs had elevated total
amylase levels. Four patients had elevated pancreatic
amylase isoenzyme levels, and the proportion of
amylase activity that was pancreatic in origin was
43%, 47%, 53%, 68%, and 78%. Six hours after oper-
ation, seven of 31 patients (23%) with rupture had
elevated total amylase levels. Four patients had ele-
vated pancreatic amylase levels, and the proportion
of amylase activity that was pancreatic in origin was
17%, 21%, 23%, 75%, 81%, 84%, and 92%. Elevated
total serum amylase level was a more common find-
ing in patients after repair of non-ruptured AAA (5
of 10 for non-ruptured AAA vs 7 of 31 for ruptured
AAA), but this did not reach statistical significance.
The median (range) values for total amylase level
and salivary and pancreatic amylase isoenzyme levels
before operation and 6 hours after aortic clamp
release are shown in Table I, and salivary and pancre-
atic amylase isoenzyme levels are illustrated in Figs 1
and 2, respectively. Before surgery, salivary amylase
levels were significantly lower in cases of ruptured
AAA as compared with cases of non-ruptured AAA (P
= .05), and there was no significant difference in pan-
creatic amylase levels between the groups. After
surgery, there was no significant difference in salivary
amylase levels between the groups, but pancreatic
amylase levels were significantly higher in patients
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Fig 1. Salivary amylase levels before and 6 hours after operation in patients who underwent
operation for ruptured and non-ruptured abdominal aortic aneurysm. Values are median
(range). Mann-Whitney test was used for statistical analysis.
RAAA, Ruptured abdominal aortic aneurysm; nonRAAA, non-ruptured abdominal aortic
aneurysm.
with non-ruptured AAA (P < .02). The median
(range) relative contribution of the pancreatic amylase
isoenzyme level to the total amylase level is shown in
Table II. In patients with ruptured AAA, there was no
significant difference in preoperative and postopera-
tive pancreatic amylase levels and in postoperative sali-
vary amylase levels between survivors and non-sur-
vivors. Fig 3 shows that preoperative salivary amylase
isoenzyme levels were, however, significantly lower in
non-survivors of ruptured AAA (P < .05), such that a
level equal to or less than 45 U/L was associated with
death in 11 of 13 patients (85%).
DISCUSSION
This study is the largest study to report serum
amylase levels in patients who underwent operation
for ruptured and non-ruptured AAA and is the first
to examine the source of serum amylase and the
prognostic significance of its isoenzymes in these
patient groups.
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Fig 2. Pancreatic amylase levels before and 6 hours after operation in patients who underwent
operation for ruptured and non-ruptured abdominal aortic aneurysm. Values are median
(range). Mann-Whitney test was used for statistical analysis.
RAAA, Ruptured abdominal aortic aneurysm; Non RAAA, non-ruptured abdominal aortic
aneurysm.
Table I. The median (range) values for total amylase and pancreatic and salivary amylase isoenzyme levels
before operation and 6 hours after aortic clamp release in patients who underwent operation for ruptured
and non-ruptured abdominal aortic aneurysm
No. of
Preoperative amylase level (U/L) Postoperative amylase level (U/L)
patients Total Pancreatic Salivary Total Pancreatic Salivary
Ruptured AAA
Survivors 20 147 (26 – 313) 49 (12 – 174) 64 (14 – 205) 126 (50 – 952) 57 (19 – 876) 57 (24 – 346)
Postoperative deaths 12 106 (48 – 186) 61 (19 – 95) 47 (29 – 119) 139 (82 – 593) 67 (39 – 481) 57 (35 – 152)
Intraoperative deaths 8 101 (42 – 171) 42 (20 – 142) 27 (18 – 119) — — —
Non-ruptured AAA 10 157 (100 – 223) 68 (27 – 108)  89 (47 – 143) 208 (101 – 357) 119 (25 – 279) 78 (43 – 164)
AAA, Abdominal aortic aneurysm.
It has been speculated that hyperamylasemia that
occurs in patients with ruptured AAA and after aortic
surgery is pancreatic in origin and is associated with a
poor prognosis. Pancreatic injury is a recognised com-
plication of aortic reconstruction.4-8 In a retrospective
study of 95 patients who underwent post-mortem
examination after AAA repair, Warshaw and O’Hara9
found evidence of major pancreatic injury (defined as
acute pancreatitis, pancreatic necrosis, or pancreatic
abscess) in four of 32 patients (12%) who underwent
operation for non-ruptured AAA and in 18 of 63
patients (29%) who underwent operation for rup-
tured AAA. Bagley et al3 reported elevated total amy-
lase activity in four of 25 patients (16%) on admission
to hospital with ruptured AAA and in 10 of 23
patients (43%) after surgery. In a further retrospective
study of 12 patients who had elevated total serum
amylase levels after ruptured AAA repair, salivary amy-
lase level was elevated in nine patients and pancreatic
amylase was elevated in six patients.10
Several causes for pancreatic injury in ruptured
AAA repair have been postulated and include: tissue
hypoperfusion and ischemia caused by hypovolemic
shock9; ischemia caused by embolization of atheroma-
tous debris into the pancreatic arteries4; ischemia
caused by supracoelic aortic clamp placement; duode-
nal, pancreatic, or biliary duct compression from the
adjacent ruptured aneurysm5,7; and direct trauma dur-
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Fig 3. Salivary amylase level before operation in non-survivors and survivors of ruptured
abdominal aortic aneurysm repair. Values are median (range). Mann-Whitney test was used for
statistical analysis.
Table II. Median (range) relative contribution of pancreatic amylase isoenzyme level to the total amylase
level before operation and 6 hours after aortic clamp release in patients who underwent operation for rup-
tured and non-ruptured abdominal aortic aneurysm
Median (range) relative contribution of pancreatic amylase level to total amylase level (%)
No of patients Before operation Six hours after aortic clamp release
Ruptured AAA
Survivors 20 40 (18 – 66) 43 (17 – 82)
Postoperative deaths 12 47 (36 – 62) 57 (28 – 85)
Intraoperative deaths 8 52 (18 – 83) —
Non-ruptured AAA 10 39 (26 – 67) 56 (25 – 78)
AAA, Abdominal aortic aneurysm.
ing dissection of the neck of the aneurysm and clamp
placement. In this study, there was no significant rela-
tionship between preoperative or postoperative pan-
creatic amylase and operation time, aortic clamp time,
and operative blood loss in patients with ruptured or
non-ruptured AAA. Although no patients required
supracoelic aortic clamping, neither of the two patients
with juxtarenal ruptured AAA who required supra-
renal clamping had elevated pancreatic amylase isoen-
zyme levels before or 6 hours after operation.
Before operation, total amylase was predomi-
nantly salivary in origin in patients who underwent
operation for non-ruptured AAA, in survivors of
ruptured AAA, and in patients who died after repair
of ruptured AAA. After operation, total amylase was
predominantly salivary in origin only in survivors of
rupture (Table II). Before operation, total amylase
level was elevated in one patient with non-ruptured
AAA who had a healthy pancreatic amylase isoen-
zyme level and in five patients with ruptured AAA,
only one of whom had an elevated pancreatic amy-
lase isoenzyme level. Six hours after operation, pan-
creatic amylase isoenzyme level was elevated in four
of five patients with non-ruptured AAA and elevated
total amylase levels, and in four of seven patients
with ruptured AAA and elevated total amylase levels.
There was no significant difference in preoperative
pancreatic amylase levels between patients with rup-
tured and non-ruptured AAA or between survivors
and non-survivors of rupture, and, six hours after
operation, pancreatic amylase levels were significant-
ly lower in the ruptured aneurysm group. Six hours
after operation, an elevated total amylase level was a
more common finding in patients who underwent
operation for non-ruptured AAA (5 of 10 vs 7 of 31
with ruptured AAA), but this difference did not
reach statistical significance. Despite the fact that
this is the largest series of patients with ruptured and
non-ruptured AAAs studied thus far, the authors
recognize that, with the low number of patients who
underwent operation for non-ruptured AAA, there
is a low statistical power for detecting any significant
difference between the groups.
The hypothesis that hyperamylasemia in ruptured
AAA is a marker of ischemic pancreatic injury and is
associated with poor prognosis3 is not, therefore, sup-
ported by this study. The study has, however, shown
a strong association between low levels of salivary
amylase isoenzyme before operation and mortality in
patients who undergo operation for ruptured AAA.
The mechanism behind this finding is a matter of
speculation. It is not the practice of this department
to give large volumes of intravenous fluid to patients
with ruptured AAA before the aorta is clamped: an
increase in blood pressure may disturb the equilibri-
um between aortic blood pressure and retroperitoneal
tamponade and lead to fatal aortic hemorrhage before
the patient reaches the operating room.11,12 There-
fore, intravenous crystalloid or colloid is infused to
maintain a systolic blood pressure of approximately 90
mm Hg. Despite this, hematocrit levels before opera-
tion were significantly lower in non-survivors than in
survivors of ruptured AAA, which may be the result
of the translocation of body fluid from the extravas-
cular to the intravascular compartment, which is
known to occur during the early stages of hypov-
olemic shock.13 Hemodilution may, therefore, have
contributed to the lower salivary amylase levels in
non-survivors. It has been suggested that salivary
amylase level is a marker of lung injury because ele-
vated levels have been reported in patients with pneu-
monia and pulmonary infarction. Furthermore, in a
study of 101 patients who underwent cardiac surgery,
Kazmierczak and Van Lente14 demonstrated a signif-
icant positive correlation between peak levels of sali-
vary amylase and severity of postoperative pleural
effusion. The authors suggested that pulmonary cap-
illary endothelial cell injury and increased pulmonary
permeability may allow salivary amylase to be
absorbed into the circulation. One possible explana-
tion for the low salivary amylase levels in non-sur-
vivors of ruptured AAA is that the state of whole body
hypoperfusion and ischemia leads to increased salivary
amylase levels within those tissues capable of produc-
ing it (salivary glands, small intestine, kidney, and
lung) but that reduced or absent reperfusion does not
lead to “wash out” and absorption of the salivary
amylase into the systemic circulation.
In conclusion, these data do not support the
hypothesis that hyperamylasemia is a marker of
ischemic pancreatic injury and is associated with
poor outcome in patients who undergo operation
for ruptured AAA. By contrast, low preoperative lev-
els of salivary amylase isoenzyme were associated
with increased mortality in cases of ruptured AAA.
Salivary amylase level may be a marker of extent of
whole body hypoperfusion, and hemodilution in
patients with ruptured AAA and its measurement on
admission to a hospital may be of assistance in the
identification of those patients who are at increased
risk of perioperative death.
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